Hair Restoration Surgery Explained: Candidacy, Process, Results

Most hair loss content goes straight to technique: FUE versus FUT, manual versus robotic, shaved versus unshaven. Those comparisons matter, but they skip an earlier question. Before any man chooses a method or a clinic, he needs to know whether he is a surgical candidate at all.

This guide answers that question with clinical detail. It explains what happens in hair transplant surgery and is built around two concepts that much of the popular coverage leaves out: donor dominance theory and Norwood-Hamilton staging. Readers will learn why transplanted hair keeps growing, how surgeons assess candidacy using objective criteria rather than desire or budget, what results are realistic, and where medications such as finasteride and minoxidil fit afterward.

It is meant as a reference to read before choosing a technique. It is not a pitch for any clinic or method.

What Hair Restoration Surgery Actually Is

In a hair transplant, a dermatologist or cosmetic surgeon takes hair-bearing skin or individual follicular units from a donor area and places them in a bald or thinning area. Each graft holds one to several hairs. In some techniques, the surgeon removes a strip of skin that contains many hair groupings.

The American Academy of Dermatology notes that the procedure usually takes 4 to 8 hours, depending on the number of grafts. It is done as outpatient surgery under local anesthesia, so patients go home the same day.

It is just as important to understand what the surgery does not do. MedlinePlus states that a hair transplant cannot create new hair. It moves hair the patient already has. That is why a candidate must have thick, healthy hair on the back or sides of the scalp, with enough follicles available to move.

Why Moved Hair Keeps Growing: The Donor Dominance Theory

Hair transplantation rests on a principle called donor dominance. Follicles taken from the permanent zone at the back and sides of the scalp keep their original genetic growth traits after they are moved to a balding area.

The reason is biological. Male pattern baldness is driven by dihydrotestosterone (DHT), a hormone that gradually shrinks follicles that are genetically sensitive to it. Follicles in the back and sides of the scalp are naturally resistant to DHT. When a surgeon moves them to the crown or hairline, they keep growing as they would have in their original location.

This explains why a transplant is permanent rather than a temporary cosmetic fix. The new location does not protect the hair. The hair’s origin does. It also explains why candidacy depends so heavily on how much of that resistant donor hair a patient has.

Who Is a Candidate? Why Norwood-Hamilton Staging Matters More Than Desire or Budget

Candidacy does not depend mainly on wanting surgery or being able to pay for it. It depends on whether a man has enough healthy, stable donor hair to redistribute. Surgeons measure that with the Norwood-Hamilton scale.

The American Society of Plastic Surgeons says candidates generally need healthy hair growth at the back and sides of the head to serve as a donor area. Hair color, texture, waviness, and curl also affect the cosmetic result. Coarse, curly, or low-contrast hair (hair close in color to the skin) can give more apparent coverage per graft than fine, straight hair that contrasts sharply with the scalp.

The Norwood-Hamilton Scale is the standard clinical system for classifying male pattern baldness. It records how much hair has already been lost and, by implication, how much donor hair remains.

What the Norwood-Hamilton Scale Measures

The scale has seven stages:

• Stages 1 and 2: Little or slight recession at the temples.
• Stage 3: Clear recession at the temples, the first stage generally considered clinical balding. A variant (3 Vertex) adds thinning at the crown.
• Stages 4 and 5: Deeper frontal recession and a growing bald spot at the crown, with the band of hair between them gradually thinning.
• Stage 6: The band between the front and crown is gone, leaving one large bald area.
• Stage 7: Advanced, near-total baldness, with only a narrow horseshoe of hair around the sides and back.

The scale is more than a description of appearance. Surgeons use it to judge the pattern and severity of loss against the donor supply that remains. A higher stage means more area to cover and often less donor hair to cover it with.

Stage-by-Stage: Where Surgical Candidacy Is Strongest, and Where It Breaks Down

Early stages (1 to 3): Surgery is often premature. The pattern of loss has not settled, so a surgeon cannot predict where future thinning will occur. Medical treatment alone is often the better choice at this point.

Mid-stage (Stage 4): This is often the strongest range for surgery. Stage 4 shows marked frontal recession and a distinct bald spot at the crown, separated by a band of hair. Enough donor hair usually remains, and the areas of loss are well defined, so a surgeon can plan with confidence.

Advanced stage (Stage 6): Donor supply becomes the main limit. The surgeon must assess the available donor area carefully to decide what is achievable. Patients may need to prioritize, for example by restoring a natural frontal hairline instead of covering the entire scalp.

End-stage (Norwood 7): Often little or no usable donor hair remains. A transplant may be difficult or impossible unless body hair is used as an additional source.

As the stage advances, the question changes from “Can I get the look I want?” to “How much donor hair is there to work with?“

Who Is Not a Good Surgical Candidate

Several groups are poor candidates, and reputable surgeons say so openly:

• Patients with diffuse unpatterned alopecia. According to the Journal of the American Academy of Dermatology (JAAD) and other dermatologic literature, these patients are generally not good candidates. Their thinning extends into the zone that would normally serve as the donor area, which limits the hair available to move.
• Very young patients. JAAD advises caution about transplants in men in their early 20s. Their hair loss is likely still progressing, and native hair can keep thinning around a transplant, leaving an unnatural pattern later.
• Patients with unrealistic expectations. Surgery does not stop hereditary hair loss across the scalp, and it rarely restores the density of a man’s original hairline. Patients who expect either outcome need a frank discussion before going ahead.

Patients are getting younger. The ISHRS 2025 Practice Census found that 95% of first-time surgical patients in 2024 were aged 20 to 35. Because so many patients are now young, careful assessment of donor stability matters more, not less.

What Happens During the Procedure

This section covers the steps shared by all methods rather than comparing techniques.

Modern grafting moves hair in small, natural groupings of one to several hairs. According to the AAD, this replaced the older “plug” method and gives a much more natural result.

Surgeons harvest donor hair in different ways. Strip excision (FUT) removes a narrow band of scalp. Follicular unit extraction (FUE) removes individual follicular units. Pen-based implantation (DHI) loads grafts into a hollow-needle device and places them in one motion. These choices matter, but they come after candidacy is settled.

The ISHRS 2025 Census gives typical graft counts:

• 2,262 grafts on average for FUE cases
• 2,100 grafts on average for FUT cases
• 2,347 grafts on average for first-time procedures

Robotic-assisted FUE (the ARTAS system, FDA-cleared since 2011) is still uncommon. It accounts for only about 1.3% of procedures among ISHRS members. It is one option among several and is not automatically better.

Consultation and Donor Evaluation

Every legitimate procedure starts with a thorough consultation. The surgeon will:

• Assign a Norwood stage
• Measure donor density at the back and sides of the scalp
• Discuss hair color, texture, and curl and how they will affect the result
• Review the patient’s history of hair loss and its likely progression

Poor candidates should be identified here, before anything is scheduled. This includes patients with diffuse alopecia, too little donor hair, or unrealistic goals.

Procedure Day: Harvesting, Preparation, and Implantation

Whatever the technique, the day usually follows this order:

1. Local anesthesia is given to the donor and recipient areas.
2. Donor grafts are harvested by strip or individual extraction.
3. Grafts are prepared and sorted under magnification, usually by one-, two-, and three-hair units.
4. Grafts are implanted in the recipient area according to a hairline design planned in advance, with attention to angle, direction, and density.

Genetic (androgenetic) hair loss accounts for 70.9% of surgical cases, according to analysis of the 2025 ISHRS census. That is why donor dominance and Norwood staging form the core clinical framework: they describe the condition most patients have.

Recovery Timeline and What Results Realistically Look Like

Hair transplant surgery is an outpatient procedure. According to WebMD, most people return to work and normal activity 2 to 5 days afterward.

Results take time. Growth does not start right away, and the early weeks can look discouraging.

The Growth Timeline, Month by Month

• Months 1 to 2: The scalp heals, and many transplanted hairs shed. The area may look much as it did before surgery.
• Months 3 to 5: Transplanted hair usually begins to grow again, though it is fine and short at first.
• Months 6 to 9: Hairs thicken and lengthen, and coverage improves noticeably.
• Months 9 to 12: Results mature.

Cleveland Clinic says it can take up to a full year to see the complete result of any hair transplant. This is the normal timeline. Disappointment in months 1 and 2 is common and does not mean the procedure failed.

Shedding Is Normal, Not a Sign of Failure

The American Society for Dermatologic Surgery explains that transplanted hair often falls out early on, and a new hair later grows from the same follicle. This is a normal resting phase. The grafts have not died.

Some patients also develop folliculitis, an inflammation of the hair follicles, around the time new growth starts. WebMD notes that some of the original hair around the treated area can fall out temporarily, a phenomenon called shock loss. In most cases these hairs grow back. Shock loss is different from permanent graft failure.

Multiple Sessions Are Common, Not a Sign Something Went Wrong

According to the ISHRS 2025 Census, patients needed an average of 1.5 procedures to reach the result they wanted, with a median of 1. A second touch-up session is part of many patients’ plans and does not mean the first surgery failed.

Mayo Clinic agrees that patients may need more than one surgery to get the effect they want. It also notes that hereditary hair loss will keep progressing elsewhere on the scalp despite surgery.

Risks, Complications, and the Limits of Surgery

Patients should understand the risks and limits before deciding on surgery.

Common risks are usually manageable:

• Bleeding
• Bruising
• Swelling
• Infection
• Folliculitis
• Temporary shock loss

FUE is the most widely used technique because it is minimally invasive and recovery is quick. Clinical literature still documents a range of possible complications with it. Patient satisfaction depends on sound technique and realistic planning.

Cost is another limit. Mayo Clinic notes that insurance usually does not cover surgery for baldness because it is generally classed as cosmetic.

The most important limit is the one described in the candidacy section. Hereditary hair loss continues in areas that were not transplanted, no matter how successful the surgery is. A transplant treats loss that has already happened in a defined area. It does not prevent future loss across the scalp.

Where Medication Fits In After Surgery

Medication protects the native hair around a transplant. It does not boost the transplant itself, because transplanted follicles are already resistant to DHT through donor dominance.

Transplanted hair does not need medication to survive. Finasteride, dutasteride, and minoxidil help preserve the native hair that was not moved. That hair remains genetically sensitive to DHT and can keep thinning.

What the Clinical Literature Says

JAAD’s clinical overview states that successful medical treatment is key to stopping the progression of hair loss. It offers a better chance of a lasting result over time because it protects the surrounding hair that frames the transplanted area. The same literature says surgeons should tell patients clearly that donor hair is limited, that hair loss will continue, and that medical therapy can play an important supporting role.

Reviews of post-transplant care state that medical therapy (finasteride or dutasteride plus minoxidil) should be prescribed for transplant patients with androgenetic alopecia in Norwood-Hamilton stages 1 through 5, to prevent thinning of non-transplanted hair.

Medication is optional for surgical success. Using finasteride or minoxidil after a transplant does not change how well the grafts take. It helps preserve the surrounding native hair over the years.

Physician views are changing. According to ISHRS census data, the share of physicians comfortable recommending oral minoxidil alongside surgery rose from 26% in the 2022 Census to 65% in the 2025 Census. More surgeons now use it as an optional complement to surgery.

A Practical Way to Think About Post-Surgical Medication

• Surgery treats hair already lost in a defined area.
• Medication is a separate, ongoing way to keep the hair that remains everywhere else.

This is where a doctor-guided daily regimen can help. Some men are not yet surgical candidates under Norwood staging. Others are planning surgery and want to protect their native hair afterward. For both groups, a formula that combines minoxidil and dutasteride, such as Thryve Hair Lab’s compounded once-daily capsule, is a simple and consistent way to support non-transplanted hair over the long term. It protects existing hair. It does not replace or enhance surgical results.

Starting early matters. Donor supply is limited and native hair loss is progressive, so beginning a protective regimen before or after a candidacy evaluation keeps more options open later, including surgical ones.

Who Is Getting Hair Restoration Surgery in 2026

The patient population is changing:

• Patients are younger. 95% of first-time patients in 2024 began treatment between ages 20 and 35, a much younger group than the general adult population.
• More women are seeking surgery. Female surgical patients increased 16.5% between 2021 and 2024 among ISHRS members, the fastest-growing group.
• The specialty is well defined. As of late 2026, there are 603 ISHRS-certified hair restoration physicians across 69 countries and territories, 156 of whom are Fellow members.
• New approaches are expected. In ISHRS physician surveys, hair cloning (28%) and stem cell therapies (27%) are the most anticipated next advances. These may eventually ease today’s dependence on donor hair, but for now donor supply still determines what surgery can do.

Conclusion: Candidacy Comes Before the Procedure Decision

The first question is not FUE versus FUT or which clinic to choose. It is whether a man’s Norwood stage and donor density make him a viable candidate.

Results last because of donor dominance. Moved follicles keep the DHT resistance of their original location, so outcomes in the transplanted area are permanent.

Realistic expectations are clear:

• Growth takes 3 to 12 months.
• Early shedding is normal.
• A second procedure is common.
• Surgery does not stop hereditary loss elsewhere on the scalp.

Finasteride, dutasteride, and minoxidil protect the native hair around a transplant and support long-term results. They are an added safeguard. They are not required for the surgery to succeed, and they do not improve the transplanted hair itself.

Men can use this information as the basis for a conversation with a qualified provider, whether the next step is a surgical consultation or a protective medical regimen in the meantime.

Protect the Hair You Still Have, Starting Today

Protecting existing hair can start now, whether a man is years from surgical candidacy, considering a consultation, or recovering from a procedure.

Thryve Hair Lab offers a doctor-formulated, once-daily 4-in-1 capsule combining minoxidil, dutasteride, biotin, and vitamin D3. It provides a convenient, clinically grounded way to support long-term hair health without managing several separate products.

• Formulated with input from board-certified hair transplant surgeons and restoration specialists
• Prescribed only after review by a licensed medical provider
• Delivered discreetly in travel-friendly packaging
• Backed by a 1-year satisfaction guarantee

The online questionnaire takes a few minutes. A licensed provider then reviews the answers to determine whether a doctor-guided daily regimen is appropriate for the patient’s stage of hair loss and builds a personalized plan from there.